These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11045863)

  • 1. Predictors of compliance with naltrexone among alcoholics.
    Rohsenow DJ; Colby SM; Monti PM; Swift RM; Martin RA; Mueller TI; Gordon A; Eaton CA
    Alcohol Clin Exp Res; 2000 Oct; 24(10):1542-9. PubMed ID: 11045863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes.
    Monti PM; Rohsenow DJ; Swift RM; Gulliver SB; Colby SM; Mueller TI; Brown RA; Gordon A; Abrams DB; Niaura RS; Asher MK
    Alcohol Clin Exp Res; 2001 Nov; 25(11):1634-47. PubMed ID: 11707638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What role does measuring medication compliance play in evaluating the efficacy of naltrexone?
    Baros AM; Latham PK; Moak DH; Voronin K; Anton RF
    Alcohol Clin Exp Res; 2007 Apr; 31(4):596-603. PubMed ID: 17374038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial.
    Guardia J; Caso C; Arias F; Gual A; Sanahuja J; Ramírez M; Mengual I; Gonzalvo B; Segura L; Trujols J; Casas M
    Alcohol Clin Exp Res; 2002 Sep; 26(9):1381-7. PubMed ID: 12351933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial.
    Galloway GP; Koch M; Cello R; Smith DE
    BMC Psychiatry; 2005 Apr; 5():18. PubMed ID: 15804355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining ondansetron and naltrexone treats biological alcoholics: corroboration of self-reported drinking by serum carbohydrate deficient transferrin, a biomarker.
    Ait-Daoud N; Johnson BA; Javors M; Roache JD; Zanca NA
    Alcohol Clin Exp Res; 2001 Jun; 25(6):847-9. PubMed ID: 11410720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone in the treatment of alcohol dependence.
    Krystal JH; Cramer JA; Krol WF; Kirk GF; Rosenheck RA;
    N Engl J Med; 2001 Dec; 345(24):1734-9. PubMed ID: 11742047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone's effect on cue-elicited craving among alcoholics in treatment.
    Monti PM; Rohsenow DJ; Hutchison KE; Swift RM; Mueller TI; Colby SM; Brown RA; Gulliver SB; Gordon A; Abrams DB
    Alcohol Clin Exp Res; 1999 Aug; 23(8):1386-94. PubMed ID: 10470982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers.
    Davidson D; Saha C; Scifres S; Fyffe J; O'Connor S; Selzer C
    Addict Behav; 2004 Aug; 29(6):1253-8. PubMed ID: 15236831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients.
    Pettinati HM; Volpicelli JR; Pierce JD; O'Brien CP
    J Addict Dis; 2000; 19(1):71-83. PubMed ID: 10772604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
    Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone in the treatment of alcoholism: predicting response to naltrexone.
    Volpicelli JR; Clay KL; Watson NT; O'Brien CP
    J Clin Psychiatry; 1995; 56 Suppl 7():39-44. PubMed ID: 7673104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted versus daily naltrexone: secondary analysis of effects on average daily drinking.
    Hernandez-Avila CA; Song C; Kuo L; Tennen H; Armeli S; Kranzler HR
    Alcohol Clin Exp Res; 2006 May; 30(5):860-5. PubMed ID: 16634855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted naltrexone for early problem drinkers.
    Kranzler HR; Armeli S; Tennen H; Blomqvist O; Oncken C; Petry N; Feinn R
    J Clin Psychopharmacol; 2003 Jun; 23(3):294-304. PubMed ID: 12826991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment.
    O'Malley SS; Garbutt JC; Gastfriend DR; Dong Q; Kranzler HR
    J Clin Psychopharmacol; 2007 Oct; 27(5):507-12. PubMed ID: 17873686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone?
    Rubio G; Ponce G; Rodriguez-Jiménez R; Jiménez-Arriero MA; Hoenicka J; Palomo T
    Alcohol Alcohol; 2005; 40(3):227-33. PubMed ID: 15797885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.